In the article titled “Novel Pharmacomechanical Thrombolysis for Treating Intermediate-Risk Acute Pulmonary Embolism: The Bashir Endovascular Catheter,”¹ published online 15 December 2021, the Texas Heart Institute Journal editorial staff inadvertently changed thrombotomy to thrombectomy. The following sentence on page 2 of the PDF should read as follows: “The novel Bashir Endovascular Catheter (BEC) (Thrombolex, Inc.) enables both targeted thrombolytic delivery and mechanical thrombotomy to fragment thrombus and promptly restore alveolar blood flow in the presence of acute PE.”